-
TheraPEAK® LV Nucleocuvette® Cartridge, weldable (5 pcs)Catalog #: G4LN-7520W
For use in combination with TheraPEAK® Nucleofector® Solution Sets, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Sales unit: items -
Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 100 million, with cell type frequencyCatalog #: CC-2703P
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells with cell type frequency information
Sales unit: each -
4D-Nucleofector® LV UnitCatalog #: AAF-1002L
For closed, scalable large-scale transfection of up to 1x109 cells.
Sales unit: items -
TheraPEAK® P3 Primary Cell Nucleofector® Solution Set (22.5 mL + 5 mL)Catalog #: G4LP3-22500
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Sales unit: items -
TheraPEAK® 4D-Nucleofector® LV Reservoirs, weldable (5 pcs)Catalog #: G4LR-1501WFor use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.Sales unit: items
-
Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 50 million, w/cell population frequencyCatalog #: CC-2702P
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells with cell population frequency information
Sales unit: each -
TheraPEAK® P3 Primary Cell Nucleofector® Solution Set (126 mL + 28 mL)Catalog #: G4LP3-126000
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Sales unit: items -
HIAEC – Human Iliac Artery Endothelial CellsCatalog #: CC-2545HIAEC, Iliac Artery Endothelial CellsSales unit: each
-
HMVEC-Bd – Human Bladder Microvascular Endothelial CellsCatalog #: CC-7016HMVEC-Bd, Bladder Microvascular Endothelial CellsSales unit: each
-
HMVEC-C – Human Cardiac Microvascular Endothelial CellsCatalog #: CC-7030
Cryopreserved ampule of Human Cardiac Microvascular Endothelial Cells (HMVEC-C) containing ≥ 500,000 cells
Sales unit: each
-
References - X-Vivo™Overview of relevant references
-
Primary Normal Human Cells and MediaIn Vivo Relevance. In Vitro Results. Updated and revised cell content.
-
TechSheet - X-VIVO™ Media SystemsInstructions for how to use the X-VIVO™ Media Series
-
TheraPEAK® T-VIVO® Cell Culture Medium – OverviewView or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
-
TheraPEAK® X-VIVO® Hematopoietic Cell Culture MediumSerum-free, GMP produced medium for cell therapy applications
-
Non-viral Gene Modification for Ex-vivo Cell TherapyIn this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
-
Terms and Conditions TheraPEAK T-VIVO Sample Request Program
-
4D-Nucleofector® LV Unit for Large-scale TransfectionEfficient, closed and scalable transfection for ex vivo cell and gene therapy applications
-
A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
-
Clonetics™ and Poietics™ Disease CellsIn Vivo Relevance. In Vitro Results. Product listings on Poster Six disease cell lines are identified:Airway, Skeletal Muscle,Adipose, Cardiac, Renal and Dermal